Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
Standard
Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence. / Holtfreter, Martha C; Mischlinger, Johannes; Davi, Saskia Dede; Schleenvoigt, Benjamin T.
in: EUR J MED RES, Jahrgang 28, Nr. 1, 12.07.2023, S. 231.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Kommentar › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Investigation on birth weight outcomes in schistosomiasis and praziquantel research: a correspondence
AU - Holtfreter, Martha C
AU - Mischlinger, Johannes
AU - Davi, Saskia Dede
AU - Schleenvoigt, Benjamin T
N1 - © 2023. The Author(s).
PY - 2023/7/12
Y1 - 2023/7/12
N2 - Infection with Schistosoma sp. during pregnancy can cause low birth weight of the newborn. To allow a better differentiation between newborns with low birth weight and those with normal weight, the terms of intrauterine growth restriction (IUGR), small for gestational age (SGA) or fetal growth restriction (FGR) should be used. FGR describes the relationship between birth weight and gestational age and is defined as the incapability of a fetus to achieve expected growth with birth weight below the 10th percentile for gestational age. Additional investigations of the proportion of newborns with FGR should obtain more certainty about the effect of praziquantel and schistosomiasis on fetal growth.
AB - Infection with Schistosoma sp. during pregnancy can cause low birth weight of the newborn. To allow a better differentiation between newborns with low birth weight and those with normal weight, the terms of intrauterine growth restriction (IUGR), small for gestational age (SGA) or fetal growth restriction (FGR) should be used. FGR describes the relationship between birth weight and gestational age and is defined as the incapability of a fetus to achieve expected growth with birth weight below the 10th percentile for gestational age. Additional investigations of the proportion of newborns with FGR should obtain more certainty about the effect of praziquantel and schistosomiasis on fetal growth.
KW - Infant, Newborn
KW - Female
KW - Pregnancy
KW - Humans
KW - Praziquantel/therapeutic use
KW - Birth Weight
KW - Schistosomiasis/drug therapy
KW - Fetus
U2 - 10.1186/s40001-023-01202-7
DO - 10.1186/s40001-023-01202-7
M3 - Comment/debate
C2 - 37434209
VL - 28
SP - 231
JO - EUR J MED RES
JF - EUR J MED RES
SN - 0949-2321
IS - 1
ER -